CLDX EBITDA Margin
Celldex Therapeutics Inc · EBITDA Margin

CLDX EBITDA Margin
Latest reported-265353.57%period ending
CLDX TTM EBITDA Margin (145.45% → -265353.57%)
TTM ebitda margin
High-resolution chart · PNG
CLDX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -265,353.5714% | |
| -34,185.6098% | |
| -17,028% | |
| -8,505.7308% | |
| -3,389.121% | |
| -2,322.8205% | |
| -2,203.5043% | |
| -1,431.245% | |
| -1,673.5606% | |
| -2,200.9223% | |
| -1,892.2272% | |
| -2,787.8121% | |
| -3,388.8786% | |
| -3,414.0635% | |
| -4,322.8681% | |
| -8,894.6197% | |
| -10,709.2233% | |
| -1,779.3045% | |
| -1,420.4643% | |
| -688.387% | |
| -581.6431% | |
| -922.1622% | |
| -615.3971% | |
| -1,054.7024% | |
| -1,082.3971% | |
| -981.6448% | |
| -1,390.0644% | |
| -1,150.4494% | |
| -1,079.6491% | |
| -921.2389% | |
| -761.357% | |
| -751.9505% | |
| -653.5571% | |
| -630.1434% | |
| -816.2678% | |
| -972.0634% | |
| -1,218.3462% | |
| -1,709.2205% | |
| -1,834.9985% | |
| -1,902.5216% | |
| -2,356.9172% | |
| -2,067.3813% | |
| -2,290.6934% | |
| -2,406.8899% | |
| -2,336.8752% | |
| -3,239.2779% | |
| -3,249.5538% | |
| -3,910.1136% | |
| -3,825.0767% | |
| -4,258.1164% | |
| -1,909.4381% | |
| -1,022.2892% | |
| -694.952% | |
| -527.9531% | |
| -487.4933% | |
| -499.3293% | |
| -497.8353% | |
| -462.6116% | |
| -419.2337% | |
| -0.808% | |
| 4.3411% | |
| 6.6475% | |
| 9.9694% | |
| -248.9605% | |
| -213.8783% | |
| -217.954% | |
| -217.8575% | |
| -212.5454% | |
| -253.9969% | |
| -284.8672% | |
| -422.0055% | |
| -468.5957% | |
| -602.8398% | |
| -539.4278% | |
| -333.5371% | |
| -553.064% | |
| -612.8262% | |
| -908.2245% | |
| -411.0979% | |
| -337.4321% | |
| -280.7482% | |
| -248.3487% | |
| -541.8883% | |
| -337.8868% | |
| -346.4911% | |
| -312.6385% | |
| -173.0132% | |
| -211.226% | |
| -140.2195% | |
| -124.4898% | |
| -220.1472% | |
| -233.3842% | |
| -126.0065% | |
| -166.8399% | |
| -191.0498% | |
| -236.3173% | |
| -740.5556% | |
| -718.7293% | |
| -666.59% | |
| -759.9948% |